In this annual screening program, they demonstrated a decreasing trend in the median serum PSA levels in men diagnosed with prostate cancer, when comparing the 5 year periods of 2000–2005 and 2006–2011, with a corresponding increase in low stage disease (T1c).
← all excerpts
Findings from a prostate cancer screening program in a Japanese population.
1
—
—